Literature DB >> 13515078

[Method for studying chylomicrons].

K H SOERGEL.   

Abstract

Keywords:  FATS/in blood

Mesh:

Substances:

Year:  1957        PMID: 13515078     DOI: 10.1007/bf01485729

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  27 in total

1.  Blood levels of absorbed labeled fat and chylomicronemia.

Authors:  W W BURR; C DUNKELBERG; J C McPHERSON; H C TIDWELL
Journal:  J Biol Chem       Date:  1954-10       Impact factor: 5.157

2.  The heparin-like action of treburon in abolishing alimentary lipemia in normal individuals.

Authors:  R F ACKERMAN; D B ZILVERSMIT
Journal:  Circulation       Date:  1953-04       Impact factor: 29.690

3.  Chylomicron dissolution; dosage and site of action of heparin.

Authors:  R L SWANK; S W LEVY
Journal:  Am J Physiol       Date:  1952-10

4.  Fat-loading studies in relation to age.

Authors:  J HERZSTEIN; C I WANG; D ADLERSBERG
Journal:  AMA Arch Intern Med       Date:  1953-08

5.  Chemical nature of the ultramicroscopic particles of serum.

Authors:  R N Cunningham; B A Peters
Journal:  Biochem J       Date:  1938-09       Impact factor: 3.857

6.  Ultramicroscopic particles in normal human blood.

Authors:  A C Frazer; H C Stewart
Journal:  J Physiol       Date:  1937-06-17       Impact factor: 5.182

7.  Relationship between relapsing pancreatitis and essential hyperlipemia.

Authors:  G KLATSKIN; M GORDON
Journal:  Am J Med       Date:  1952-01       Impact factor: 4.965

8.  Fat absorption and chylomicronemia.

Authors:  L MARDER; G H BECKER; B MAIZEL; H NECHELES
Journal:  Gastroenterology       Date:  1952-01       Impact factor: 22.682

9.  A study of serum fat globules in atherosclerotic and non-atherosclerotic male subjects.

Authors:  W J ZINN; G C GRIFFITH
Journal:  Am J Med Sci       Date:  1950-12       Impact factor: 2.378

10.  The stabilization of serum lipid emulsions by serum phospholipids.

Authors:  E H AHRENS; H G KUNKEL
Journal:  J Exp Med       Date:  1949-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.